New Evolution in The Management of Atopic Dermatitis

Introduction

Take This Event

We are pleased to invite you to the webinar titled ‘New Evolution in the Management of Atopic Dermatitis’ presented by Prof. Kristian Reich.

Objectives

Prof. Kristian Reich will discuss:
- why targeting JAK1/2 in atopic dermatitis improves atopic dermatitis skin signs and symptoms.
- what implications targeting JAK1/2 might have on safety signals.
- the importance of interpreting safety concerns as well as JAK selectivity in the context of the safety profile in clinical trials.
- what implication Baricitinib molecule characteristics beyond JAK inhibition have on clinical practice.

See Registration Policies, Cancellations & Refunds